These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1228251)
41. Anti-ulcer actions of phytosphingosine hydrochloride in different experimental rat ulcer models. Baek SW; Kim NK; Jin HJ; Koh CW; Kim CK; Kwon OH; Kim JS; Cho MH; Park CK Arzneimittelforschung; 2005; 55(8):461-5. PubMed ID: 16149714 [TBL] [Abstract][Full Text] [Related]
42. Dopamine disorder in duodenal ulceration. Szabo S Lancet; 1979 Oct; 2(8148):880-2. PubMed ID: 90970 [TBL] [Abstract][Full Text] [Related]
43. Glutathione and ascorbic acid concentrations in the duodenum of rats with cysteamine-induced ulcers: influence of cysteine and ascorbic acid pretreatments. Ali BH; Abdel Gayoum AA; Bashir AA; el-Fakhri M Pharmacology; 1990; 40(5):258-64. PubMed ID: 2274572 [TBL] [Abstract][Full Text] [Related]
44. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers in rats. Kunizaki C; Sugiyama M; Tsuchiya S Scand J Gastroenterol Suppl; 1989; 162():218-21. PubMed ID: 2595299 [TBL] [Abstract][Full Text] [Related]
45. Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating γ-glutamylcysteine synthetase. Choi KS; Kim EH; Hong H; Ock CY; Lee JS; Kim JH; Hahm KB J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():13-22. PubMed ID: 22486866 [TBL] [Abstract][Full Text] [Related]
46. Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids. Jayaraj AP; Tovey FI; Lewin MR; Clark CG J Gastroenterol Hepatol; 2000 Jun; 15(6):610-6. PubMed ID: 10921413 [TBL] [Abstract][Full Text] [Related]
47. Role of prostanoids in experimental duodenal ulcer in rat. Kauffman GL; Kolve E; Walfisch S; Mangus J Dig Dis Sci; 1988 Jun; 33(6):667-72. PubMed ID: 3131076 [TBL] [Abstract][Full Text] [Related]
48. Diamine oxidase activity in the duodenal mucosa of rats with cysteamine-induced ulceration. Ali BH; Bashir AA Pharmacology; 1992; 44(5):269-72. PubMed ID: 1620722 [TBL] [Abstract][Full Text] [Related]
49. Effect of tyrosine administration on duodenal ulcer induced by cysteamine in the rat. Oishi T; Szabo S J Pharmacol Exp Ther; 1987 Mar; 240(3):879-82. PubMed ID: 3559979 [TBL] [Abstract][Full Text] [Related]
50. Changes in duodenal mucosal blood flow and mucus glycoprotein content during cysteamine-induced duodenal ulceration in rats. Kurebayashi Y; Asano M; Hashizume T; Akashi A Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):152-62. PubMed ID: 4051635 [TBL] [Abstract][Full Text] [Related]
51. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine. Scarpignato C; Tangwa M; Tramacere R; Del Soldato P Digestion; 1986; 33(1):7-16. PubMed ID: 2866139 [TBL] [Abstract][Full Text] [Related]
52. Duodenal ulcerogens cysteamine and propionitrile decrease duodenal neutralization of acid in the rat. Adler RS; Gallagher GT; Szabo S Dig Dis Sci; 1983 Aug; 28(8):716-23. PubMed ID: 6872804 [TBL] [Abstract][Full Text] [Related]
53. Duodenal ulcerogens cysteamine and propionitrile induce gastroduodenal motility alterations in the rat. Pihan G; Kline TJ; Hollenberg NK; Szabo S Gastroenterology; 1985 Apr; 88(4):989-97. PubMed ID: 3972237 [TBL] [Abstract][Full Text] [Related]
54. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. Fukuhara S; Suzuki H; Masaoka T; Arakawa M; Hosoda H; Minegishi Y; Kangawa K; Ishii H; Kitajima M; Hibi T Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G138-45. PubMed ID: 15778430 [TBL] [Abstract][Full Text] [Related]
55. [Evaluation of gastric emptying and pyloric loss in cysteamine-induced duodenal ulcer]. Kikuchi K; Harasawa S; Miwa T Nihon Shokakibyo Gakkai Zasshi; 1982 May; 79(5):1183. PubMed ID: 7131869 [No Abstract] [Full Text] [Related]
56. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer. Szabo S; Pihan G; Gallagher GT; Brown A Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493 [TBL] [Abstract][Full Text] [Related]
57. Effects of a new sigma ligand, JO 1784, on cysteamine ulcers and duodenal alkaline secretion in rats. Pascaud XB; Chovet M; Soulard P; Chevalier E; Roze C; Junien JL Gastroenterology; 1993 Feb; 104(2):427-34. PubMed ID: 8425684 [TBL] [Abstract][Full Text] [Related]
58. Cysteamine-induced duodenal ulcer and the hepatoduodenal branch of the vagus nerve. Kato K; Watanabe T; Itoh M; Yoshida S; Hoshino N; Itoh K; Sugimura F; Iwasaki A; Matsuo Y; Sawai H Gastroenterol Jpn; 1990 Jun; 25(3):314-9. PubMed ID: 1972686 [TBL] [Abstract][Full Text] [Related]
59. From cysteamine to MPTP: structure-activity studies with duodenal ulcerogens. Szabo S; Cho CH Toxicol Pathol; 1988; 16(2):205-12. PubMed ID: 3055230 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of cysteamine-induced duodenal ulcer in the rat by bile diversion. Enhancement of the ulcerogenic effect of cysteamine by taurocholic and glycocholic acids. Clémençon GH; Fehr HF Scand J Gastroenterol; 1983 Jan; 18(1):13-6. PubMed ID: 6675171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]